Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Illinois at Chicago
Age
45–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subjects will have moderate to severe COPD. Severity of COPD will be defined according to the new GOLD standards (moderate IIA (moderate), 50% \< FEV1 \< 80% predicted; moderate IIB (severe) 30% \< FEV1 \< 50%). 58
Insomnia. Insomnia will be defined as difficulty initiating or maintaining sleep, waking up too early or poor quality sleep. 59
Subjects must be \> 45 years of age with no other major health problems
Subjects must be clinically stable at the time of enrollment into the study without major exacerbation of COPD within the previous two months.
You may not be if
Evidence of restrictive lung disease or asthma.
Evidence of a major sleep disorder other than insomnia (sleep apnea evidenced by apnea/hypopnea index of \> 10, periodic limb movement disorder, narcolepsy).
Hypnotic, sedative, anxiolytic or antidepressant use.
Pulse oximetry (SaO2) reading of \< 90% at rest.
Pulse oximetry (SaO2) reading of \< 85% at night for \> 5 minutes.
Significant sleep apnea (apnea/hypopnea index ≥ 10).
.Acute respiratory infection within the previous 2 months.
Class \> 2 functional status according to the New York Heart Association.
The presence of a potentially debilitating disease such as cancer, congestive heart failure, kidney disease, liver failure or cirrhosis; evidence of alcohol or drug abuse, musculoskeletal or degenerative nerve disease.
A self-reported current diagnosis of major depression or psychiatric disease or a Hospital Anxiety and Depression Scale (HADS) depression score of \> 11.
Currently participating in pulmonary rehabilitation.
Clareo Health | Cognitive Behavioral Therapy for Insomnia in People With Chronic Obstructive Pulmonary Disease(COPD)
